临床试验/NCT01628601

NCT01628601已完成不适用

GANfort® in Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Are Insufficiently Responsive to Monotherapy

Allergan0 个研究点目标入组 392 人开始时间: 2010年5月最近更新: 2012年9月24日

适应症

干预措施

试验速览

阶段: 不适用
状态: 已完成
发起方: Allergan
入组人数: 392
主要终点: Change From Baseline in Intraocular Pressure (IOP)

研究概览研究设计入排标准研究组 & 干预措施结局指标研究者记录与标识符相似试验

研究概览

简要总结

This is an observational study of patients diagnosed with Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) who are insufficiently responsive to monotherapy and who are prescribed GANfort® (fixed combination of 0.3 mg bimatoprost and 5 mg timolol) by their physician.

研究设计

研究类型: Observational
观察模型: Cohort
时间视角: Prospective

入排标准

性别: All
接受健康志愿者: 否

入选标准

•Diagnosis of primary open angle glaucoma or ocular hypertension
•Prescribed GANfort® (fixed combination 0.3 mg bimatoprost and 5 mg timolol)

排除标准

未提供

研究组 & 干预措施

POAG or OHT

Patients with POAG or OHT prescribed GANfort® (fixed combination 0.3 mg bimatoprost and 5 mg timolol) treatment in a dose determined by the physician prior to study entry

干预措施: Fixed combination 0.3 mg bimatoprost and 5 mg timolol (Drug)

结局指标

主要结局

Change From Baseline in Intraocular Pressure (IOP)

时间窗: Baseline, 18 Weeks

IOP is a measurement of the fluid pressure inside the eye. A negative change from baseline indicates an improvement.

次要结局

Physician Assessment of Adherence to GANfort®(18 Weeks)
Physician Assessment of Tolerability Using a 4-Point Scale(18 Weeks)
Patient Assessment of Tolerability Using a 4-Point Scale(18 Weeks)
Patients Continuing With GANfort® After 18 Weeks(18 Weeks)

研究者

发起方

Allergan

申办方类型

Industry

责任方

Sponsor

相似试验

已完成

不适用

A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Switched to Lumigan® UD Monotherapy for Medical ReasonsGlaucoma, Primary Open AngleOcular Hypertension

NCT01853085Allergan1,830

已完成

不适用

Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)Glaucoma, Open-AngleOcular Hypertension

NCT01628588Allergan854

招募中

不适用

Effects of Primary Open-angle Glaucoma on Visual-motor CoordinationPrimary Open-angle Glaucoma

NCT06692205Zhongshan Ophthalmic Center, Sun Yat-sen University200

已完成

3 期

Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution in Subjects With Open-Angle Glaucoma or Ocular HypertensionOpen-Angle GlaucomaOcular Hypertension

NCT01749930Bausch & Lomb Incorporated420

已完成

3 期

Comparing Safety and Efficacy of BOL-303259-X With Timolol Maleate in Subjects With Open-Angle Glaucoma or Ocular HypertensionOcular HypertensionOpen-Angle Glaucoma

NCT01749904Bausch & Lomb Incorporated420